MedTrace Logo

The Invia Motion at Cesarean Study

NCT04365452 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-05-11

Study results available
· View outcomes & findings →

Summary

To assess patient centered outcomes of the Medela INVIA Motion prophylactic NPWT system at cesarean delivery.

Conditions

  • Negative Pressure Wound Therapy
  • Cesarean Section; Infection

Interventions

DEVICE

Invia Motion

Invia Motion NPWT system at cesarean delivery

Sponsors & Collaborators

  • Medela AG

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Principal Investigators

  • Methodius Tuuli, MD, MPH · Indiana University School of Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-10
Primary Completion
2020-08-31
Completion
2020-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365452 on ClinicalTrials.gov